Collegium Pharmaceutical, Inc. ( COLL) - Key Metrics
COLL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $6.16 | -$0.46 | $2.20 | $2.18 |
| 2026Q1 | $6.03 | $0.45 | $1.78 | $1.77 |
| 2025Q4 | $6.48 | $0.54 | $3.88 | $3.86 |
| 2025Q3 | $6.63 | $1 | $2.48 | $2.48 |
| 2025Q2 | $5.91 | $0.38 | $2.28 | $2.28 |
COLL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -19.67 |
| 2026Q1 | 0% | 18.37 |
| 2025Q4 | 0% | 21.44 |
| 2025Q3 | 0% | 8.75 |
| 2025Q2 | 0% | 19.45 |
COLL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 6.03% | 0% |
| 2026Q1 | 5.36% | 0% |
| 2025Q4 | 8.34% | 0% |
| 2025Q3 | 7.08% | 0% |
| 2025Q2 | 7.69% | 0% |
COLL
Price: $23.19
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.27 USD
P/E Ratio: 21.42
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 465500
Ebitda: -13.3 millionMarket Capitalization: 711.3 million